|
π’
|
Pathophysiology and management of pulmonary infections in cystic fibrosis.
R. Gibson,
J. Burns,
B. Ramsey
|
10 |
2003 |
10
π’
|
|
π
|
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group.
9 auth.
H. Fuchs,
D. Borowitz,
D. H. Christiansen,
Edward M Morris,
Martha L. Nash,
B. Ramsey,
...
B. Rosenstein,
Arnold L. Smith,
M. Wohl
|
10 |
1994 |
10
π
|
|
π
|
Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patients.
13 auth.
E. Smith,
D. Buckley,
Zaining Wu,
C. Saenphimmachak,
L. Hoffman,
David A. D'Argenio,
Samuel I. Miller,
B. Ramsey,
D. Speert,
S. Moskowitz,
...
J. Burns,
R. Kaul,
M. Olson
|
10 |
2006 |
10
π
|
|
π
|
Elexacaftor-Tezacaftor-Ivacaftor for Cystic Fibrosis with a Single Phe508del Allele.
21 auth.
P. Middleton,
M. Mall,
P. DΕevΓnek,
L. Lands,
E. McKone,
Deepika Polineni,
B. Ramsey,
J. Taylor-Cousar,
E. Tullis,
F. Vermeulen,
...
G. Marigowda,
C. Mckee,
S. Moskowitz,
N. Nair,
J. Savage,
C. Simard,
S. Tian,
D. Waltz,
F. Xuan,
S. Rowe,
R. Jain
|
10 |
2019 |
10
π
|
|
π¦
|
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
12 auth.
B. Ramsey,
M. Pepe,
Joanne M. Quan,
K. Otto,
A. Montgomery,
J. WilliamsβWarren,
...
Michael Vasiljev-K,
D. Borowitz,
C. M. Bowman,
B. Marshall,
S. Marshall,
Arnold L. Smith
|
10 |
1999 |
10
π¦
|
|
π¬
|
Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis
J. Emerson,
M. Rosenfeld,
S. Mcnamara,
B. Ramsey,
R. Gibson
|
10 |
2002 |
10
π¬
|
|
π
|
Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial
64 auth.
HarryG. M. Heijerman,
E. McKone,
D. Downey,
E. V. Braeckel,
S. Rowe,
E. Tullis,
M. Mall,
J. Welter,
B. Ramsey,
C. Mckee,
G. Marigowda,
S. Moskowitz,
D. Waltz,
P. Sosnay,
C. Simard,
...
N. Ahluwalia,
F. Xuan,
Yaohua Zhang,
J. Taylor-Cousar,
K. McCoy,
K. McCoy,
S. Donaldson,
Seth Walker,
J. Chmiel,
R. Rubenstein,
D. Froh,
I. Neuringer,
M. Jain,
K. Moffett,
J. Taylor-Cousar,
Bruce Barnett,
Gary Mueller,
P. Flume,
Floyd Livingston,
N. Mehdi,
C. Teneback,
J. Welter,
R. Jain,
D. Kissner,
Kapilkumar Patel,
Francisco J. Calimano,
J. Johannes,
C. Daines,
T. Keens,
H. Scher,
S. Chittivelu,
Sudhakar Reddivalam,
R. Klingsberg,
L. Johnson,
S. Verhulst,
P. Macedo,
D. Downey,
G. Connett,
E. Nash,
N. Withers,
Timothy Lee,
M. Bakker,
HarryG. M. Heijerman,
F. Vermeulen,
C. Knoop,
E. Wachter,
R. V. D. Meer,
P. Merkus,
C. Majoor
|
9 |
2019 |
9
π
|
|
π’
|
Effect of VX-770 in persons with cystic fibrosis and the G551D-CFTR mutation.
26 auth.
F. Accurso,
S. Rowe,
J. Clancy,
M. Boyle,
J. Dunitz,
P. Durie,
S. Sagel,
D. Hornick,
M. Konstan,
S. Donaldson,
R. Moss,
J. Pilewski,
R. Rubenstein,
A. Uluer,
M. Aitken,
...
S. Freedman,
Lynn M. Rose,
N. Mayer-Hamblett,
Q. Dong,
J. Zha,
A. Stone,
E. Olson,
C. OrdonΜez,
P. Campbell,
M. Ashlock,
B. Ramsey
|
9 |
2010 |
9
π’
|
|
π’
|
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis.
11 auth.
J. Burns,
R. Gibson,
S. Mcnamara,
Darlene L. Yim,
J. Emerson,
M. Rosenfeld,
...
P. Hiatt,
K. McCoy,
R. Castile,
Arnold L. Smith,
B. Ramsey
|
9 |
2001 |
9
π’
|
|
π¦
|
Management of pulmonary disease in patients with cystic fibrosis.
B. Ramsey
|
8 |
1996 |
8
π¦
|
|
π¦
|
Efficacy of aerosolized tobramycin in patients with cystic fibrosis.
12 auth.
B. Ramsey,
H. Dorkin,
J. Eisenberg,
R. Gibson,
I. Harwood,
R. Kravitz,
...
D. Schidlow,
R. Wilmott,
S. Astley,
M. McBurnie,
K. Wentz,
Arnold L. Smith
|
8 |
1993 |
8
π¦
|
|
π’
|
Clinical mechanism of the cystic fibrosis transmembrane conductance regulator potentiator ivacaftor in G551D-mediated cystic fibrosis.
12 auth.
S. Rowe,
S. Heltshe,
T. Gonska,
S. Donaldson,
D. Borowitz,
D. Gelfond,
...
S. Sagel,
Umer Khan,
N. Mayer-Hamblett,
J. V. Van Dalfsen,
E. Joseloff,
B. Ramsey
|
8 |
2014 |
8
π’
|
|
π
|
Microbiology of sputum from patients at cystic fibrosis centers in the United States.
8 auth.
J. Burns,
J. Emerson,
Jennifer R. Stapp,
Darlene L. Yim,
J. Krzewinski,
Laurie Louden,
...
B. Ramsey,
C. Clausen
|
8 |
1998 |
8
π
|
